MCMolka Chaieb

Molka Chaieb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Molka Chaieb has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evolution of premature ovarian failure after 15 years of follow-up

    by Najoua Lassoued, Abdelkrim Asma Ben, Yosra Hasni, Maha Kacem, Molka Chaieb, Amel Maaroufi, Ach Koussay El

    Introduction: The therapeutic management of premature ovarian failure (POF) consists of a hormone replacement therapy that must be regular to avoid cardiovascular and bone complications as well as psychological management. The objective of this work was to study complications at 15 years of evolution of 42 tunisian women followed for POF. Patients and methods: It’s a retrospective study of 42 patients followed in the endocrinology department of Sousse for POF between 2000 and 2017. Results: The average age of the patients was 23.85 years old. All patients were treated with combined estrogen/progestin hormone replacement therapy with a sequential regimen in 11 patients to ensure withdrawal bleeding. After 15 years of follow-up on average, a final small height was found in 5 patients with an average height of 147.85 cm. The average body mass index was 24.51 kg/m2. The average waist circumference was 90,5 cm. Three patients became diabetic, one patient was followed for hypertension and one patient was followed for dyslipidemia. Metabolic syndrome criteria were met in one third of patients. No patient had a cardiovascular event. Bone densitometry showed osteoporosis in 21.43% of patients and osteopenia in 35.71% of patients. Two patients had pathological fracture at the age of 28 and 39, respectively. Therapeutic non-compliance of hormone replacement therapy was observed in 20% of patients. Conclusion: The two major risks of hypoestrogenism secondary to POF are cardiovascular risk and bone risk. If the patient is substituted, these risks should be avoided. However, few studies have prospectively evaluated the effects of estrogen therapy on cardiovascular risk in patients with POF.

  • Associated pituitary insufficiencies in children with growth hormone deficiency

    by Taieb Ach, Yosra Hasni, Asma Ben Abdelkarim, Amel Maaroufi, Maha Kacem, Molka Chaieb, Monia Zaouali, Koussay Ach

    Context: GH deficiencies could be associated with other pituitary insufficiencies. Our main objective is to assess othe pituitary secretion in short stature patients. Patients and methods: Twenty three patients (17 boys, 6 girls) were included in the study for exploration of short stature, after oral and informed consent of their parents, from January 2016 to June 2017 in the Department of Endocrinology of the University Hospital of Farhat Hached Sousse. The mean age of the patients was 11.30±2.83 years. Patients were excluded if they had a known chromosomal abnormality, untreated primary hypothyroidism, metabolic disease or disease associated with disordered glucose metabolism, MRI abnormalities, a known endocrine abnormality that could interfere with HPA axis function, were treated by any kind of steroid preparation, or had an anatomic abnormality or tumor of the central nervous system, a history of central nervous system irradiation, or documented central or primary hypothyroidism. The Inslin Tolerance Test (ITT) was performed by administering an IV bolus injection of 0.10 U/kg regular human insulin (Actrapid*). The Glucagon Stimulation Test (GST) was performed by intramuscular injection of 1 mg glucagon. We assessed the other pituitary axis by hormonal assays: TSH and T4 for the thyroid deficiency, ACTH and cortisol for adrenal insufficiency and Gonadotrophins for gonadic axis. Results: From 23 children with short stature, 15 had GH deficiency (GHD) confirmed by both of Insulin tolerance test and Glucagon stimulation test. The mean age of the patients was 10.67±3.24 yo. The mean height was 164.33±4.22 cm, with a standard derivation (SD) of −2 DS for 53.3% and −3 DS for 46.7%. Hypophysary MRI performed in 6 children was normal. The bone age was of 10.13±2.85 yo. They were 12 boys and 3 girls. The mean peak of GH under ITT and GST was respectively of 1.95±1.04 ng/ml and 2.92±1.7 ng/ml significantly lower than normal children (P−3). Of the children with GHD, 5 of them had secondary adrenal insufficiency confirmed by both of ITT and GST, 3 of them had hypogonadotropic hypogonadism and 1 of them had central hypothyroidism. None of them had hyperprolactinemia. Conclusion: GH deficiency could be associated with other pituitary insufficiencies that may be asymptomatic in children with short stature. Assessing the entire pituitary secretion may discover these deficiencies and permit earlier treatment.

  • Etiological profile of premature ovarian failure: about 42 cases

    by Najoua Lassoued, Asma Ben Abdelkrim, Yosra Hasni, Maha Kacem, Molka Chaieb, Amel Maaroufi, Ach Koussay El

    Introduction: Premature ovarian failure (POF) is defined as amenorrhea lasting more than four months before the age of 40 with a high level of gonadotropins in at least two separate samples. The aim of this work was to describe the etiological profile of a series of Tunisian women followed for POF. Patients and methods: It is a descriptive study of 42 cases of POF collected in the endocrinology department of Sousse between 2000 and 2017. Results: The average age of the patients was 23.85 years old. Thirty patients consulted for primary amenorrhea with an average age of 18.8 years and 12 patients consulted for secondary amenorrhea with an average age of 36.5 years. Eleven patients reported irregular periods before the installation of secondary amenorrhea while the beginning was brutal in the twelfth. A family history of primary sterility was found in two patients, a family autoimmunity field was found in two patients, whereas no history of early menopause was found in our patients. Nine patients were followed for type 1 diabetes, six patients for primary hypothyroidism and one patient for celiac disease. The hormonal profile showed an average FSH level of 90.7 mIU/ml, an average LH level of 49.82 mIU/ml and an average estradiol level of 21.42 pg/ml. The karyotype was requested in all patients who consulted for primary amenorrhea. It showed a mosaic Turner syndrome in two of our patients. In addition, the immunological survey showed positive anti-ovarian antibodies in one patient. At the end of this investigation, an autoimmun origin of POF was retained in 38% of patients and a genetic origin related to Turner syndrome in 4,76% of patients. The POF was idiopathic in 57,24% of our patients. Discussion and conclusion: The POF is not an exceptional pathology. The most commun etiologies are at the present time sterilizing treatments such as chemotherapy or radiotherapy. Genetically, abnormalities of the X chromosome, in particular Turner syndrome, are identified. Most often, after a thorough clinical investigation, no etiology is found. Indeed, idiopathic POF still accounts for more than 75% of cases.

  • Clinical aspects of the schmidt's syndrome: a 14 years retrospective monocentric study

    by Taieb Ach, Asma Ben Abdelkarim, Yosra Hasni, Safa Khaldi, Amel Maaroufi, Maha Kacem, Molka Chaieb, Koussay Ach

    Introduction: Schmidt’s syndrome also known as autoimmune polyglandular syndrome type 2 (APS type 2) is a rare endocrine disorder defined by the combined occurrence of Addison disease with autoimmune thyroid disease. The rarity of the condition and the atypical presentation of adrenal insufficiency and hypothyroidism often lead to misdiagnosis with life-threatening consequences for the patient. In this study we report an exhaustive monocentric analysis of 22 patients diagnosed with a Schmidt’s Syndrome. Patients and methods: We carried out a retrospective study of all the patients diagnosed of a Schmidt syndrome or APS type 2 in the Department of Endocrinology and Diabetology of University Hospital Farhat Hached of Sousse, over a period from 1999 to 2013. Adrenal insufficiency was diagnosed with a basal cortisol levelP=0.02) and a predominance for female sex with a sex ratio=0.22 (P−3). The mean age of discovery of Addison’s disease was 32.5±9.2 with extremes ranging from 12 to 58 years. According to the age of discovery compared to hypothyroidism, Addison disease was diagnosed significantly before the diagnosis of Hashimoto’s disease in 59% (P=0.03), concomitant in 27.2% and posterior in 13.6%. Clinical symptoms made of melanodermia and hypoglycaemia suggested the diagnosis in 47% of all patients. An acute adrenal insufficiency was triggered by the hormonal thyroxin substitution in one case. Other autoimmune diseases were found in 27.2%, as a celiac disease (8%), type 1 diabetes (8%), Biermer anemia (7%) and autoimmune ovaritis in 4.2%. Conclusion: Schmidt’s Syndrome is more likely to be associated with the female sex and young age. In our study, Hashimoto’s hypothyroidism was the first autoimmune disease discovered. The presence of at least one component of the APS type 2 must lead to the autoimmune screening of the other diseases. This screening could avoid the triggering of an adrenal insufficiency in thyroid hormonal substitution.

  • Diagnostic difficulties of Pseudo-Cushing states in women: about 24 cases

    by Najoua Lassoued, Yosra Hasni, Maha Kacem, Molka Chaieb, Amel Maaroufi, Koussay El Ach

    Introduction: Differentiation between mild Cushing’s syndrome (CS) and Pseudo-Cushing syndrome (PCS) can be extremely difficult. A Pseudo-Cushing state can be defined as a part or all of the clinical features that resemble a true CS with some evidence of hypercotisolism but the resolution of the underlying primitive state results in the disappearance of this Cushing state-like. The aim of this work was to describe the diagnostic difficulties of 24 cases of PCS. Patients and methods: A descriptive study of 24 women referred to the endocrinology department for suspicion of CS. Results: The mean age of the patients was 33.3 years old. Nine patients were followed for hypertension, 7 for type 2 diabetes and 2 for depression. On examination, the average body mass index was 41.43 kg/m2. The average waist circumference was 118.5 cm. With respect to CS elements, 83.33% of patients had truncal obesity, 29.16% had facial erythrosis, 16.66% had buffalo hump, 16.66% had hirsutism, 8.33% had acne, 16.66% had purple stretch marks and 16.66% has intertrigo. No patient had muscular atrophy or bruising. In the biology, the fasting glucose level was 1.41 g/L on average, the mean triglyceride level was 1.25 g/L and the mean HDL-cholesterol level was 0.44 g/L. About one third of these patients had a metabolic syndrome. The overnight dexamethasone suppression test was negative in 50% of our patients whereas the standard 2-day dexamethasone suppression test was positive in all our patients which allowed us to retain rather the diagnosis of a PCS. Abdominopelvic ultrasound showed hepatic steatosis in seven patients and ovarian dystrophy in one patient. Bone densitometry was requested in two patients with a normal bone profile for age. Discussion and conclusion: Pseudo-Cushing states share many of the characteristics of CS, including overproduction of cortisol. The hypercotisolism of PCS is caused by the increased activity of the CRH neuron which stimulates the production and release of ACTH. Despite the fact that some symptoms are more specific to CS than PCS, the diagnosis depends always on laboratory results.

  • Long-term follow-up of congenital adrenal hyperplasia due to 11[beta]-hydroxylase deficiency

    by Hamza Elfekih, Yosra Hasni, Wafa Badr, Asma Ben Abdelkrim, Bilel Ben Amor, Amal Maaroufi, Maha Kacem, Molka Chaieb, Moez Gribaa, Koussay Ach, et al.

    Introduction: Congenital adrenal hyperplasia (CAH) due to an enzymatic defect in 11-beta-hydroxylase (11β-OHD) is the second most common cause of CAH representing 5-8% of cases. It is characterized by androgen excess, hypertension and hypokalemia. Here we describe the case of a patient having a CYP11B1 mutation and being followed-up during 33 years. Observation: A 36-year-old Tunisian male was diagnosed with 11β-OHD at the age of three years revealed by precocious pseudopuberty. Laboratory findings was characterized by high serum concentrations of 11-deoxycortisol (656 nmol/l), high ACTH level (1500 pg/ml) and low plasma renin activity (0.7 ng/ml). A homozygous p.G379V mutation in exon 7 of the CYP11B1 gene was found. The patient was issued from consanguineous marriage. He had three other family members having the same disease and all treated by hydrocortisone. He had two healthy children aging respectively of three and one-year-old. Acute adrenal deficiency didn’t occur during the follow-up. Hypertension associated with hypokalemia was discovered 23 years later and treated by calcium channel blocker. It has been complicated only by hypertensive retinopathy grade 1. The patient had a metabolic syndrome. He had an android fat distribution (BMI=31.5 kg/m2 and 102 cm abdomen circumference), a height of 169 cm, a normal external genitalia examination and bone density. The patient had normal glucose and triglyceride level with hypoHDLemia (0.23 g/l). Discussion: CAH is an inherited autosomal recessive genetic endocrine disease. It is a group of diseases resulting from the deficiency of one of the steroidogenesis enzymes. 21-hydroxylase deficiency is the most common followed by 11β-OHD. In 11β-OHD, the p.G379V mutation found in our case in addition to the p.Q356X mutation have been described in Tunisian population. There is no systematic evaluation in adulthood of patients having 11β-OHD. Little is known regarding height, bone health, diabetes and mortality in those patients.

  • Diabetic nephropathy in type 1 diabetes mellitus

    by Ines Barka, Nesrine Chikhrouhou, Amel Maaroufi, Maha Kacem, Molka Chaieb, Koussay Ach

    Nephropathy is a serious complication of Type 1 diabetes mellitus (T1DM) with a grave prognosis after the onset of proteinuria. End stage of renal disease remains the major cause of excess morbidity and premature mortality in patients with T1DM. The aims of the present study were to investigate the prevalence of diabetic nephropathy and to evaluate risk factors for its development among patients developing T1 DM. Seventy six patients with T1DM history over 20 years were included in our study. We analysed the occurrence and risk factors of diabetic nephropathy. Microalbuminuria and macroalbuminuria were defined as urinary albumin excretion 31–299 mg and 300 mg, respectively, per 24 h in at least two of three consecutive samples, kidney failure was defined as a glomerular filtration rate (GFR) P=0.012). Our study suggests that several potentially modifiable risk factors predict the development of nephropathy in type 1 diabetic patients.

  • Cytohistologic correlation of thyroid nodules

    by Ines Barka, Senda Ouerdani, Molka Chaieb, Abdelkrim Asma Ben, Amel Maaroufi, Maha Kacem, Koussay Ach

    Background: The discovery of a thyroid nodule exposes the problem of the possibility of thyroid cancer. The difficulty of management of this situation is the fact that only the histopathological examination can confirm or refute the malignancy. Fine-needle aspiration (FNA) is used as a diagnostic tool to assess thyroid nodules. The purpose of our study is to correlate the clinical, ultasonographic, the FNA results and final pathology to determine the predictors of malignancy of thyroid nodules. Patients and Methods: We conducted a retrospective study on 33 patients with thyroid nodule. Data were obtained for FNA diagnosis, demographics, findings on ultrasound, and histologic findings. Results: The average age of our patients was 41.7years±15.6 SD with a female predominance (100%). Ultrasound findings were as follows: singles nodules, multinodular goiter (MNG), and multiple nodules in respectively 48.5, 39.4 and 12,1% of cases. Thyroid function tests prior to surgery were normal in all patients. Among the 33 patients, 7 (21.2%)have malignant tumors in histological findings: Two patients had signs of locoregional compression. A case of fixed nodule was noted and one patient had cervical lymphadenopathy. On ultrasonogrqphy: the average size of the nodules was 34.0±14.5 mm, three nodules were hypoechogenic, and 1 case of mixed vascularity was diagnosed. The FNA was benign in 90.9% of cases (n=30), and indeterminate in 9.1% (n=3). Of the 30 patients with a benign FNA result, 7 were found to have carcinoma on final pathology for 23.3% false negative rate and sensitivity of 76.7%. 1 patient were found to have incidental microcarcinoma which was located in the palpated lesion. Conclusion: FNA biopsy is essential in the assessment and management of thyroid nodules. However, we report a high rate of malignancy among FNA diagnosed as benign lesions. This high rate of malignancy is the basis for our recommendation for a surgical approach for benign lesions.

  • Association de maladies auto-immunes avec le diabète de type 1

    by Taieb Ach, Yosra Hasni, Amel Maaroufi, Maha Kacem, Molka Chadli Chaieb, Koussay Ach